We identified nicotinamide phosphoribosyltransferase (NAMPT), an adipokine involved in lipid, glucose metabolism, inflammation and insulin resistance29, as a potential blood biomarker for de novo PD patients. Here, NAMPT is linked to Parkinson disease.